CTT PHARMACEUTICAL HOLDINGS, INC.
CTT PHARMACEUTICAL HOLDINGS, INC. has made 7 open-market purchases worth $2k since Sep 16, 2026, in 1 company. The latest: $335 of CTTH, filed Oct 27, 2026, scored 26 out of 100.
CEO, CTT PHARMACEUTICAL HOLDINGS, INC.
Follow CTT PHARMACEUTICAL HOLDINGS, INC., freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 27 Form 4 (opens sec.gov) |
CTTHCTT PHARMACEUTICAL HOLDINGS, INC. · CEOCEO · Penny stock: hard to trade | +0% stake | 26 | $335 5,880 at $0.06 |
— | — |
| Oct 19 Form 4 (opens sec.gov) |
CTTHCTT PHARMACEUTICAL HOLDINGS, INC. · CEOCEO · Penny stock: hard to trade | +0% stake | 26 | $114 2,000 at $0.06 |
— | — |
| Oct 6 Form 4 (opens sec.gov) |
CTTHCTT PHARMACEUTICAL HOLDINGS, INC. · CEOCEO · Penny stock: hard to trade | +0% stake | 26 | $204 3,700 at $0.06 |
— | — |
| Sep 29 Form 4 (opens sec.gov) |
CTTHCTT PHARMACEUTICAL HOLDINGS, INC. · CEOCEO · Filed late · Penny stock: hard to trade | +0% stake | 11 | $455 10,100 at $0.04 |
— | — |
| Sep 28 Form 4 (opens sec.gov) |
CTTHCTT PHARMACEUTICAL HOLDINGS, INC. · CEOCEO · Penny stock: hard to trade | +0% stake | 26 | $187 3,400 at $0.06 |
— | — |
| Sep 22 Form 4 (opens sec.gov) |
CTTHCTT PHARMACEUTICAL HOLDINGS, INC. · CEOCEO · Penny stock: hard to trade | +1% stake | 26 | $455 10,100 at $0.04 |
— | — |
| Sep 16 Form 4 (opens sec.gov) |
CTTHCTT PHARMACEUTICAL HOLDINGS, INC. · CEOCEO · Penny stock: hard to trade | +0% stake | 26 | $523 10,900 at $0.05 |
— | — |
Questions
What stock has CTT PHARMACEUTICAL HOLDINGS, INC. bought?
CTTH (CTT PHARMACEUTICAL HOLDINGS, INC.), all on the open market and reported on SEC Form 4.
When did CTT PHARMACEUTICAL HOLDINGS, INC. last buy?
Oct 27, 2026: 5,880 shares of CTTH at $0.06, $335 in all (Form 4 (opens sec.gov)).
Has CTT PHARMACEUTICAL HOLDINGS, INC. filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is CTT PHARMACEUTICAL HOLDINGS, INC. a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 27, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer